key: cord-0838810-ozjraqfs
authors: Sorrentino, L.; Guaglio, M.; Cosimelli, M.
title: In response to: Transanal surgery during COVID‐19 pandemic in Lombardy
date: 2020-07-15
journal: J Surg Oncol
DOI: 10.1002/jso.26122
sha: 80a8094206229a88b14653c36ce80948f2214fb7
doc_id: 838810
cord_uid: ozjraqfs

nan

To the Editor, Dr Hytham Hamid suggests that we perform routine preoperative fecal testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in addition to preoperative nasopharyngeal swab to screen patients undergoing transanal surgery under positive pressure. Evidence supporting possible fecal-oral transmission of the novel coronavirus-2 (SARS-CoV-2), as well as its specific tropism to the gastrointestinal tract, is accumulating day by day. 1 Despite no certain evidence of short-range airborne transmission during endoscopic or positive-pressure transanal surgical procedures, it seems reasonable that these procedures might be considered to pose high risk of viral transmission.

In our series, only 3 of 54 patients (5.5%) underwent positivepressure procedures, during which high volume, closed circuit smoke evacuation was utilized. No clinical consequences for staff were identified. We also emphasize that all of our patients were screened both clinically and by lung computerized tomography (CT) scan. In cases of positive or suspicious findings, patients were tested by nasopharyngeal swab. Moreover, we reported that we abstained from using a laparoscopic approach for anorectal surgical procedures. 

SARS-CoV-2 productively infects human gut enterocytes